The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as ...

Abridge, a generative AI platform for clinical conversations, has raised $300 million in Series E funding, bringing its valuation to a reported $5.3 billion. Andreessen Horowitz ( a16z) led the round ...

The GenAIus Challenge, launched in April 2024 by Singapore's national health tech agency, Synapxe, connected over 160 public healthcare staff – including doctors, nurses, and administrators – directly ...

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the ...

Pharma giant Novo Nordisk announced that it is terminating its contract with direct-to-consumer virtual care company Hims & Hers, which was launched less than two months ago, due to concerns about ...

At-home testing company Visby Medical announced that it has received approximately $55 million in funding, with the potential to raise an additional $10 million.

Viz.ai, a company involved in AI-backed imaging and care coordination, is collaborating with pharma giant Novartis to develop proprietary AI-powered workflows inside the Viz Oncology Suite. Viz.ai ...

Salvo Health, a digital gastrointestinal care company, raised $4 million in an extended Seed Prime round after announcing a $5 million investment in February of last year.. New investor The Artemis ...